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Copyright © 2008 JCBN Summary To determine the relative contribution of obesity and visceral white adipose tissue
(WAT) to metabolic syndrome, we developed a model that is susceptible to high-fat diet-induced
obesity and insulin resistance using male KK/Ta mice. The ratio of WAT weight to body weight
was greater in the high-fat diet group compared with the control group in 10-, 14-, and 22-
week-old mice. The increase in visceral WAT preceded development of fatty liver and insulin
resistance. Adiponectin mRNA expression in WAT was markedly decreased before the
decrease in its plasma levels or the development of insulin resistance. Insulin resistance
appeared in association with fatty infiltration and TNF-α expression in the liver in 22-week-
old mice. These data indicate that our mouse model would be useful for future studies that
investigate the role of visceral WAT and its products in the development of metabolic syndrome.
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Introduction
The intake of calorie-rich fast food and sedentary life-
styles in developed countries, including Japan, has sharply
increased the incidence of obesity [1, 2]. Obesity is not only
a serious health and economic burden, but also predisposes
a person to a variety of metabolic diseases. Metabolic
syndrome can be characterized by a group of metabolic
risk factors that includes central obesity, insulin resistance,
dyslipidemia, increased blood pressure, and nonalcoholic
fatty liver disease (NAFLD) [2, 3]. Accumulating evidence
suggests that adipose tissue is not simply an inert energy
storage depot but also functions as a major endocrine organ,
producing and releasing a variety of bioactive substances,
especially adiponectin, into the bloodstream [4].
Traditionally, leptin-deficient (ob/ob) and leptin receptor-
deficient (db/db) mice have been used for studies of obesity.
Although the ob/ob and db/db mice have many advantages
for obesity research, including studies of insulin resistance
and adipocyte dysfunction, their utility in studying meta-
bolic syndrome is limited. For example, the plasma VLDL
and LDL levels do not increase and the HDL levels are
elevated upon high-fat diet feeding, which findings are in
contrast to those often noted in humans [5]. The lipoprotein
profiles of ob/ob and db/db mice, both on a chow and high-
fat diet, are uncharacteristic of wild-type mice or humans.
Furthermore, these mice exhibit extremely high plasmaMetabolic Syndrome in High-fat Diet-fed Mice
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glucose levels at young ages (6–10 weeks old).
In the current study, we sought to determine the relative
contribution of obesity and visceral white adipose tissue
(WAT) to metabolic syndrome, insulin resistance, and
NAFLD. To this end, we developed a model that is
susceptible to high-fat diet-induced obesity and insulin
resistance using male KK/Ta mice. We selected this model
for the following reasons: i) KK/Ta mice, which are known
as an animal model of human non-insulin-dependent
diabetes mellitus, have such characteristics as moderate
obesity, polyuria, glucose intolerance, and hyperinsulinemia.
These characteristics have been shown to appear sponta-
neously at 3 months of age [6, 7]. ii) Male KK/Ta mice are
more susceptible to visceral obesity with vascular complica-
tions compared to females. Similarly in humans, metabolic
syndrome increases visceral adiposity and cardiovascular
disease risk more markedly in men than women [8]. iii) A
high-animal fat diet is thought to be a major risk factor for
metabolic syndrome. A recent review has concluded that
animal fats and omega-6/omega-9-containing plant oils can
be used to generate an obese and insulin-resistant phenotype
in rodents, whereas fish oil-fed animals do not develop these
disorders [9]. The aim of the present study was to determine
the time-course profiles of several parameters which are
characteristic of metabolic syndrome.
Materials and Methods
Animals and treatment
Male KK/Ta Jcl mice (5 weeks old, 18–20 g body weight)
were purchased from CLEA Japan Inc. (Tokyo, Japan). The
mice were individually housed in plastic cages at 24 ± 2°C
and at 45 ± 5% relatively humidity with a 12/12-h light/dark
cycle, and were given free access to food and water
throughout the experimental period. After acclimation for 1
week by feeding of a basal diet, 6-week-old KK/Ta mice
were divided into two groups of six mice each by body
weight and blood glucose level, and fed a purified powdered
basal diet or purified high-fat powdered diet containing suet
powder at 37.5 g/100 g diet (high-fat diet) (Table 1), which
were both purchased from CLEA Japan, Inc. (Tokyo, Japan)
and kept sterile. After treatment with the experimental diet
for 2, 4, 8, or 16 weeks, starved animals were sacrificed
under anesthesia with intraperitoneal injection of sodium
pentobarbital {Nembutal® (Dainippon Sumitomo Pharma
Co., Ltd., Osaka, Japan), 50 mg/kg of body weight} to
collect blood, perirenal, epididymal, mesenteric and inguinal
WAT, and liver tissue. All animal experiments and care were
conducted in conformity with the Guidelines of the Animal
Care and Use Committee of Kyoto Prefectural University of
Medicine.
Histological analysis
Small pieces of epididymal white adipose tissues and
liver were removed and rinsed with saline. The tissues were
fixed with 10% formalin and embedded in paraffin. Tissue
sections were cut at a thickness of 2.5 µm and stained with
hematoxylin and eosin. To examine the size of the white
adipocytes, the area of each adipocyte was measured in 40
cells of representative sections with Image J software
(National Institutes of Health, Bethesda, MD). The mean
value was designated as an index of the cell size.
Oral glucose tolerance test and determination of plasma
glucose, insulin, lipids, and adiponectin
The oral glucose tolerance test (OGTT) was performed
before and 4-, 8- and 16-weeks after the treatment after
overnight fasting. The mice received a 20% glucose solution
(2 g/kg). Blood samples were collected just before and
0.5, 1, and 2 h after glucose loading. Plasma glucose levels
were determined with a Glutest Ace R (Sanwa Kagaku
Kenkyusho Co., Ltd., Nagoya, Japan). Plasma adiponectin
levels were measured using the mouse adiponectin enzyme-
linked immunosorbent assay (ELISA) kit (Ohtsuka, Ltd.,
Tokyo, Japan). Asparate 2-oxoglutarate aminotransferase
(AST), alanine 2-oxoglutarate aminotransferase (ALT), blood
urea nitrogen (BUN), free cholesterol, triglyceride, non-
esterified fatty acid, and LDL-cholesterol were measured
with a Shimadzu CL8000 Clinical Chemistry Analyzer
(Shimadzu, Ltd., Tokyo, Japan).
Determination of homeostasis model assessment of insulin
resistance
The homeostasis model assessment of insulin resistance
(HOMA-IR) was calculated using glucose and insulin
concentrations obtained after 7 h of food withdrawal, using
the following formula: fasting blood glucose (mg/dl) ×
fasting insulin (µU/ml)/405. Plasma insulin levels were
Table 1. Composition of experimental diet
Basal High-fat
w/w (%)
Milk casein 20.00 24.48
DL-methionine 0.30 0.37
Corn starch 14.66 5.93
Granulated sugar 49.09 19.85
Cellulose 5.00 6.12
Suet powder 6.25 37.50
Vitamin mix (AIN-76) 1.00 1.22
Mineral mix (AIN-76) 3.50 4.28
Choline bitartrate 0.20 0.24
Calorie (kcal/100 g) 373.62 485.60
Ratio of fat/total calrie (%) 13.10 56.60S. Akagiri et al.
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measured with an insulin ELISA kit (Morinaga Institute of
Biological Science, Inc., Yokohama, Japan).
mRNA analysis
Mouse epididymal WAT and liver tissue samples were
taken and stored in an Isogen solution (Nippon Gene Co.,
Ltd., Tokyo, Japan). The mRNA expression levels of
adiponectin, tumor necrosis factor-α (TNF-α), and β-actin
as an internal control were determined by real-time poly-
merase chain reaction (PCR). Total RNA was isolated
from adipose and liver tissues by the acid guanidinium
phenol chloroform method with an Isogen kit (Nippon Gene
Co., Ltd.) and the concentration and the quality of RNA
were determined by absorbance at 260 nm and the ratio of
260 nm to 280 nm, respectively. The isolated RNA was
stored at −70°C until use in real-time PCR. For the real-time
PCR, 1 µg of extracted RNA was reverse-transcribed into
first-strand complementary DNA (cDNA) at 42°C for 40 min,
using 200 U of M-MLV reverse-transcriptase (Promega
Corporation, Madison, WI) and 0.5 µg of oligo (dT) 15
primer (Takara Bio Inc., Shiga, Japan) in a 20-µl reaction
mixture.
Real-time PCR for adiponectin and TNF-α was carried
out with a 7300 Real-Time PCR system (Applied
Biosystems, Foster City, CA) using the DNA-binding dye
SYBER Green I for the detection of PCR products. The
reaction mixture contained 12.5 µl Premix Ex Taq and
0.5 µL ROX reference dye (Code RRO41A; Takara Bio
Inc., Shiga, Japan), 1 µl custom-synthesized primers, and
2 µl cDNA (equivalent to 20 ng total RNA) to give a final
reaction volume of 25 µl. The PCR settings were as follows:
an initial denaturation for 15 s at 95°C was followed by 40
cycles of amplification for 15 s at 95°C and 31 s at 60°C,
with subsequent melting curve analysis increasing the
temperature from 60 to 95°C. The primers were designed
using a Primer Express® software (Applied Biosystems) and
had the following sequences: for adiponectin, sense 5'-
CTGGCTTTCTTCTCTTCCATGATAC-3', and antisense
5'-GTGTCGACGTTCCATGATTCTC-3' (82-bp product);
for TNF-α, sense 5'-ATCCGCGACGTGGAACTG-3',
and antisense 5'-ACCGCCTGGAGTTCTGGAA-3' (70-bp
product); and for β-actin, sense 5'-TAGCCACCTTCCAG-
CAGATGT-3', and antisense 5'-AGCTCAGTAACAGTC-
CGCCTA-3' (101-bp product). Relative quantification of
gene expression with real-time PCR data was calculated
relative to β-actin.
Data analysis
All statistical analysis was performed with the Statcel 2
software package (OMS Publishing Inc, Saitama, Japan).
We used one-way ANOVA with a Scheffe-type multiple
comparison test to compare several parameters among four
groups. All data are expressed as the means ± SE, and p
values <0.05 were considered statistically significant.
Results
Body weight gain and white adipose tissue weight
Figure 1A shows the changes in body weight of the basal
diet (control) group and the high-fat diet group, throughout
the experimental period. At the beginning of the experiment,
the average body weight of the 6-week-old mice was
21.4 ± 0.5 g, and this value increased significantly to
50.0 ± 2.1 g after 16 weeks of feeding with a high-fat
diet. There were no differences in the average body weight
between the two groups until 14 weeks of age, but body
weight tended to increase in the high-fat diet group
compared to the basal diet group in the latter half of the
experiment period. Figure 1B shows the changes in the ratio
of WAT weight to body weight of the control group and the
Fig. 1. Changes in body weight A) and the ratio of white
adipose tissue (WAT) weight to body weight (B) of the
mice fed a basal diet or a high-fat diet. The data are
expressed as the means ± SE of 5–6 mice. #p<0.05
compared with 6-week-old mice and +p<0.05 compared
with basal diet-fed mice.Metabolic Syndrome in High-fat Diet-fed Mice
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high-fat diet group in 6-, 10-, 14-, and 22-week-old mice.
The ratio of WAT weight was greater in the high-fat diet
group compared with the control group. In contrast to the
changes of body weight, the weight of white adipose tissue
was increased in 10- and 14-week-old mice treated with a
high-fat diet compared with the control group.
Histological analysis of white adipose tissue
Treatment with a high-fat diet clearly increased the
average size of adipocytes in the epididymal WAT in a time-
dependent manner (Fig. 2A and B). Compared to adipocytes
at the beginning of the experiment, the average size of
adipocytes was significantly increased by >500% in mice
Fig. 2. Histological examination of white adipose tissues (A) and the changes in the size of white adipocytes (B) obtained from basal
diet-fed and high-fat diet-fed male mice. The data are expressed as the means ± SE of 5–6 mice. #p<0.05 compared with 6-
week-old mice and +p<0.05 compared with basal diet-fed mice.
Fig. 3. Oral glucose tolerance test throughout the experiment. The oral glucose tolerance test (OGTT) was performed both before and
after the treatment after overnight fasting.S. Akagiri et al.
J. Clin. Biochem. Nutr.
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after 16 weeks of feeding with a high-fat diet. As shown in
Fig. 2B, the average size of adipocytes was significantly
larger in the high-fat diet group at the ages of 8, 10, and 14
weeks compared with the control group.
Oral glucose tolerance test
Figure 3 shows the results of the oral glucose tolerance
test in the basal diet and the high-fat diet groups for 6-, 10-,
14-, and 22-week-old mice. Fasting blood glucose levels
were <100 mg/dl in mice throughout the experiment. Blood
glucose levels at 30 min and 60 min after glucose loading
were significantly higher (>300 mg/dl) in 10-, 14-, and 22-
week-old mice than in 6-week-old mice, indicating the
glucose intolerance. There were no significant differences
between two groups throughout the experiment.
mRNA expression of adiponectin and its plasma level
Because adiponectin is reported to be decreased in
obesity, we investigated the changes in adiponectin expres-
sion in epididymal WAT and the plasma adiponectin levels
in high-fat diet-fed mice (Fig. 4A and B). The treatment
with a high-fat diet markedly decreased the adiponectin
mRNA expression in mice at 14 weeks of age compared to
the mice before treatment, and this decrease continued in
mice 22 weeks of age. There was a significant difference in
the level of adiponectin mRNA at 14 weeks of age. The
plasma levels of adiponectin tended to decrease in mice
treated with high-fat diet 14 weeks and 22 weeks of age
compared with those in 6-week-old mice.
Plasma insulin concentrations and HOMA-IR
Figure 5A and B show the changes in fasting insulin
concentration and HOMA-IR. These parameters, which are
indices of insulin resistance, did not change during the
feeding with a high-fat diet for 8 weeks, but were signifi-
cantly increased in 22-week-old mice fed a high-fat diet
for 18 weeks.
Liver histology and TNF-α mRNA expression
Because lipid accumulation in the liver accompanied with
hepatic inflammation is reported to cause insulin resistance
in high-fat diet-fed C57BL/6J Jcl mice, we investigated the
histology of the liver and hepatic expression of TNF-α. As
shown in Fig. 6A, small unstained vesicular regions in the
hepatic cell cytoplasm were increased in 14-week-old mice
fed a high-fat diet. In 22-week-old mice, larger unstained
vesicular regions were increased in the zone 3 hepatocytes.
Figure 6B shows the changes in hepatic TNF-α mRNA
expression during the experiment. This expression was
significantly increased in 22-week-old mice compared to
that in 6-week-old mice.
Blood biochemistry
A summary of the blood chemistry is shown in Table 2.
Serum levels of ALT and AST were significantly increased
in 14- and 22-week-old mice fed a basal diet and in 22-
week-old mice fed a high-fat diet compared with those in 6-
week-old mice. Serum levels of non-esterified fatty acid and
LDL cholesterol level tended to increase in 10-week-old
mice and in 22-week-old mice, respectively.
Discussion
The major finding of this study included the following:
(1) the increase in visceral adipose tissue preceded develop-
ment of fatty liver and insulin resistance; (2) the increase in
size of white adipocytes was an early event as the fist step to
Fig. 4. Changes in plasma adiponectin (A) and its mRNA
expression in epididymal white adipose tissues (B) from
high-fat diet-fed male mice. Plasma adiponectin was
measured by an ELISA kit, and the mRNA expression
levels were analyzed by the real-time PCR method. The
details of the experiments are described in the Materials
and Methods. The data are expressed as the mean ± SE
of 5–6 mice. #p<0.05 compared with 6-week-old mice
and +p<0.05 compared with basal diet-fed mice.Metabolic Syndrome in High-fat Diet-fed Mice
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Fig. 5. Changes in plasma HOMA-IR (A) and plasma insulin (B) from high-fat diet-fed male mice. Plasma insulin was measured by an
ELISA kit, and HOMA-R was calculated by the fasting plasma glucose and insulin levels. The details of the experiments are
described in the Materials and Methods. The data are expressed as the means ± SE of 5–6 mice. #p<0.05 compared with 6-week-
old mice.
Fig. 6. Histological examination of the liver (A) and changes in TNF-α mRNA expression in hepatic tissues from high-fat diet-fed
male mice (B). Liver tissues were stained with hematoxylin and eosin, and the mRNA expression levels were analyzed by the
real-time PCR method. The details of the experiments are described in the Materials and Methods. The data are expressed as the
means ± SE of 5–6 mice. #p<0.05 compared with 6-week-old mice.
Table 2. Plasma biochemical markers
Each data is the mean ± SD of 5 mice. #p<0.05 as compared with 6 week-old mice.
6 week-old 10 week-old 14 week-old 22 week-old
Basal diet High-fat Basal diet High-fat Basal diet High-fat
AST U/l 46 ± 11 48 ± 19 66 ± 5 106 ± 10# 78 ± 6 125 ± 27# 83 ± 3#
ALT U/l 53 ± 10 62 ± 11 66 ± 2 104 ± 14# 80 ± 6 135 ± 34# 95 ± 3#
BUN mg/dl 16 ± 21 8 ± 11 6 ± 12 3 ± 51 8 ± 12 8 ± 71 9 ± 1
Total cholesterol mg/dl 92 ± 12 110 ± 11 124 ± 49 2 ± 89 8 ± 14 84 ± 71 0 2 ± 8.5
Free cholesterol mg/dl 14 ± 31 2 ± 21 0 ± 01 0 ± 01 0 ± 08 ± 22 0 ± 0
Triglyceride mg/dl 42 ± 11 48 ± 13 54 ± 94 2 ± 22 20 ± 72 0 ± 22 8 ± 5
Non-esterified fatty acid µeq/l 446 ± 73 736 ± 157 612 ± 78 710 ± 95 352 ± 140 562 ± 113 497 ± 102
LDL cholesterol mg/dl 76 ± 16 122 ± 13 104 ± 12 82 ± 14 118 ± 12 90 ± 20 132 ± 25S. Akagiri et al.
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obesity; (3) adiponectin mRNA expression was markedly
decreased before the decrease in its plasma levels or the
development of insulin resistance; and (4) insulin resistance
appeared in association with fatty infiltration and TNF-α
expression in the liver. Although there were no significant
differences in several parameters between the basal diet
group and the high-fat diet group at the end of experiment
(22-week-old mice), several characteristics of the metabolic
syndrome, including visceral adipose tissue accumulation
and decreased adiponectin expression were developed more
earlier in the high-fat diet group compared to the basal diet
group.
Several risk factors comprise metabolic syndrome—
namely, central obesity, insulin resistance, hypertension,
inflammation, and dyslipidemia. The present data demon-
strate that this model exhibits many of these features. In
particular, the marked fat accumulation was observed in
visceral white adipose tissue/cells within a month after the
treatment with high-fat diet, and this accumulation preceded
the development of insulin resistance. In addition, the fat
source of the high-fat diet in this study consisted of saturated
fatty acids derived from animal fats. Saturated fatty acids
have been known to have deleterious effects on health, but
more recently, they have been specifically implicated in
activating toll-like receptor-4, leading to the expression of
inflammatory gene products [10,  11]. Although it is still
unclear how excess visceral fat triggers metabolic syndrome,
the present data clearly indicated that the high-fat diet
induced visceral fat accumulation preceding insulin
resistance. Coenen et al. [ 12] have also developed a
model of metabolic syndrome in mice fed a Western diet,
which they defined as a caloric density of 4.8 kcal/g with
42% of the calories from anhydrous milk fat and 0.15%
added cholesterol. Their model clearly demonstrated that
Western diet-induced obesity contributes to accumulation of
adipose tissue-resident macrophages and its downstream
pathophysiological consequences, such as inflammation and
insulin resistance, but that hyperlipidemia does not.
Together with our present findings, these data support the
idea that adipocytes have important implications for the
pathogenesis of diet-induced obesity, even when plasma
lipid abnormalities are not present.
In addition to the morphological changes, the function of
adipocytes in mice fed a high-fat diet may be affected by
the intracellular fat deposition. The mRNA expression of
adiponectin and its plasma levels are significantly reduced in
obese/diabetic mice [13] and humans [14]. In the present
study, the mRNA levels of adiponectin in the WAT were
markedly decreased 8 weeks after the treatment with a
high-fat diet, and this decrease preceded the decrease in the
plasma adiponectin protein levels. In addition, the decrease
in plasma adiponectin levels was correlated with the
increases in plasma insulin and HOMA-IR. These data raise
the possibility that the expression of adiponectin mRNA
might be disturbed by the accumulation of fatty acids, and
more closely related to insulin sensitivity than obesity alone.
Similar findings were reported by Yamauchi et al. [15–17],
who demonstrated that adiponectin is decreased in obesity
and deficient in mice that are lacking in specific adipose
tissues that play a causal role in the development of insulin
resistance, and that the replenishment of adiponectin might
provide a novel treatment modality for insulin resistance,
type 2 diabetes, and atherosclerosis. The present data
indicate that these mice will be useful for future studies
investigating the role of visceral WAT and its products in the
development of metabolic syndrome.
Nonalcoholic steatosis (nonalcoholic fatty liver disease,
NAFLD) is now considered a metabolic pathway to
advanced liver disease, cirrhosis and hepatocellular
carcinoma. Accumulating evidence suggests that NAFLD is
the hepatic expression of metabolic syndrome [2,  3]. In
this model, fatty infiltration into zone 3, which is similar to
NAFLD, was observed in mice fed a high-fat diet for 16
weeks, in association with the increases in serum ALT and
AST. In addition, we confirmed the increased expression of
TNF-α mRNA, an index of inflammation, in the liver
associated with the appearance of insulin resistance in
22-week-old mice. These data indicate the close association
between insulin resistance and hepatic steatosis with
inflammation. Cai et al. [18] previously demonstrated that
hepatic inflammation induced by lipid accumulation plays a
crucial role of in the development of insulin resistance. They
clearly showed that hepatic activation of IKK-β and NF-κB
in common models of obesity, high-fat diet and genetic
hyperplasia causes insulin resistance both locally in the liver
and systemically. Consequently, these mice will be useful
for future studies of the metabolic syndrome associated with
NAFLD.
In conclusion, we have developed a mouse model of
metabolic syndrome using male KK/Ta mice fed a high-fat
diet. Using this model, we plan to more precisely clarify the
mechanisms involved in the development of metabolic
syndrome, especially the association between lipid
accumulation-induced dysfunction of visceral adipocytes
and the induction of insulin resistance. In addition, the
model presented herein may be useful for the evaluation of
preventive medicine, including food factors, for obesity-
induced metabolic syndrome.
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